Novo Nordisk filed a lawsuit against Eli Lilly that alleges advertising falsely claims Wegovy is weaker than it is.

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.

What to know about the Medicare GLP-1 Bridge program, which will give certain beneficiaries access to weight loss drugs.

A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50.

Value-seeking consumers are cutting back on alcohol. The decline in alcohol consumption has been attributed to a number of shifts—from changes in socialization patterns to an abundance of GLP-1 ...

Popular -- and expensive -- GLP-1 agonists for weight loss just got a lot cheaper for many older Americans. Starting this week, the federal government is offering a selection of the brand name ...

NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. The federal government on Wednesday started offering a selection of brand-name ...